oxycodone and Benign Neoplasms

oxycodone has been researched along with Benign Neoplasms in 187 studies

Research

Studies (187)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (2.14)	18.7374
1990's	14 (7.49)	18.2507
2000's	50 (26.74)	29.6817
2010's	91 (48.66)	24.3611
2020's	28 (14.97)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Kuroki, A; Shirota, M; Takagi, S; Yasu, T	1
Coulter, P; Fallon, M; Hughes, LT; Laird, B; Raftery, D	1
Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M	1
Chu, CC; Chu, LL; Chu, YR; Ho, CH; Teng, SF; Wang, JJ	1
Arnold, S; Bennett, MI; Bromham, N; Chi, Y; Hilgart, JS; Page, AJ; Schmidt-Hansen, M	1
Abbasi, BA; Amaro-Estrada, I; Andreas, NS; Ariga, K; Bedrov, D; Bello, AK; Bouganim, N; Braam, B; Cao, Y; Capasso, R; Caro, AL; Chen, G; Chen, Y; Clark, MK; Cossio-Bayugar, R; Dong, D; Gao, D; Gao, T; Ghimire, A; Gul, F; Hamonic, LN; He, Y; Hill, JP; Hollebeek, LD; Hu, B; Iqbal, J; Jardan, YAB; Jiang, M; Jindal, K; John, B; Khan, I; Khan, M; Klarenbach, S; Kumar, V; Li, J; Li, L; Li, Z; Lin, H; Liu, C; Liu, HF; Liu, J; Liu, L; Liu, Z; Ma, R; Mach, T; Mahmood, T; Marath, U; Mathew, D; Mei, C; Muneer, S; Nakamura, J; Ni, H; Okpechi, IG; Padwal, R; Qi, A; Qin, Y; Renjitha, M; Ringrose, J; Scott-Douglas, N; Shahbaz, A; Shi, L; Shojai, S; Singh, SK; Slabu, D; Song, Y; Srivastava, RK; Sultana, N; Takeyasu, K; Tang, SS; Thompson, S; Tinwala, MM; Trinh, E; Valappil, SP; Wang, L; Wang, T; Wang, Y; Wu, W; Xi, H; Yang, M; Yang, Y; Ye, F; Yin, G; Yin, M; Yin, X; Yuan, XS; Zaidi, D; Zeng, L; Zhang, L; Zhang, Z; Zhang, ZC; Zheng, D	1
Miyashita, M; Murakami, Y; Oba, MS; Takahashi, R	1
Kalso, E; Kriikku, P; Ojanperä, I	1
Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V	2
Adile, C; Cascio, AL; Casuccio, A; Ferrera, P; Mercadante, S	1
Chiba, Y; Fujita, Y; Haratani, K; Hayashi, H; Koyama, A; Makimura, C; Matsuoka, H; Nakagawa, K; Nakura, M; Nishio, K; Ohtake, Y; Okuno, T; Sakai, K; Sakamoto, R; Takeda, M; Takegawa, N; Tanaka, K; Tsurutani, J; Yoshida, T	1
Aiki, S; Ariyoshi, K; Ikari, T; Kihara, K; Kiuchi, D; Matsuda, Y; Matsunuma, R; Miwa, S; Mori, M; Oyamada, S; Suzuki, K; Takagi, Y; Tasaki, J; Yamaguchi, T	1
Figg, WD; Smith, DM	1
Asaka, J; Kudo, K; Nihei, S; Omoto, T	1
Boland, JW	1
Hui, D; Ikari, T; Imai, K; Inoue, A; Inoue, S; Matsuda, Y; Matsumoto, Y; Matsunuma, R; Miwa, S; Mori, M; Morita, T; Okamoto, S; Satomi, E; Suzuki, K; Watanabe, H; Yamaguchi, T; Yamauchi, T; Yokomichi, N	1
Dräger, DL	1
Bumb, M; Fortunato, J; Hirsch, J; Houchard, G; Kullgren, J; Li, J; Shirilla, N	1
Mahzoni, H; Moghaddas, A; Momenzadeh, M; Naghsh, E; Sharifi, M	1
Fujimoto, H; Funato, M; Kawana, M; Kiribayashi, M; Kokubun, H; Kondo, M; Kusakabe, A; Miyasato, A; Nagatani, K; Nakamura, K; Ohno, R; Okamoto, K; Onoda, C; Ozeki, A; Suzuki, N	1
Bao, T; Chittams, J; Mao, JJ; Meghani, SH; Rosa, WE; Vallerand, AH	1
Nakajima, N	1
Duan, J; Li, D; Li, L; Tan, D; Xu, H; Yan, H; Yu, Y	1
Watanabe, K	1
Daniels, B; Holliday, S; John, TN; Liauw, W; Lovell, M; Luckett, T; Pearson, SA; Phillips, J; Rowett, D; Tervonen, H	1
Ishiki, H; Kiuchi, D; Sato, N; Satomi, E; Shimizu, M; Yoshida, T	1
Chen, L; Chen, Z; Deng, Y; Feng, W; Li, L; Liang, J; Tang, Y; Xian, H; Yang, S; Zhang, H; Zhang, S	1
Aggarwal, G; Ahmedzai, S; Douglas, C; Green, M; Le, BH; Nicoll, A	1
Dong, S; Dou, Z; Knaggs, R; Li, Y; Lu, G; Ma, J; Xia, J; Yang, L; Zhao, S	1
Amato, F; Ceniti, S; Consoletti, L; Magaldi, D; Mameli, S; Marcassa, C; Notaro, P; Palmieri, V; Pisanu, GM; Vellucci, R	1
Armstrong, H; Dinnen, T; Perkins, P	1
Arnold, S; Bennett, MI; Bromham, N; Hilgart, JS; Schmidt-Hansen, M	2
Chiba, Y; Fujita, Y; Koyama, A; Matsuoka, H; Nakagawa, K; Nishio, K; Otake, Y; Sakai, K; Terashima, M; Tsurutani, J; Yoshida, T	1
Kim, ES	1
Chen, Y; Hu, L; Li, J; Mei, Q; Peng, P; Tian, Y; Xia, S	1
Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M	1
Coma, J; De Sanctis, V; Estivill, P; Ferreras, J; Folch, J; Fuentes, J; Guitart, J; Jiménez, AJ; Moya, J; Rodelas, F; Salazar, R; Sanz, A; Tomás, A; Vargas, MI	1
Aruga, E; Inoue, S; Saito, Y; Takahashi, H; Tsuneto, S; Uemori, M	1
Deguchi, Y; Hirano, S; Kumon, A; Odagiri, T; Okumura, Y; Osada, T; Sakurai, A; Watanabe, H; Watanabe, N; Yamamoto, Y; Yamamura, K	1
Song, Z; Wang, W; Zhang, Y	1
Hisanaga, T; Imai, K; Kizawa, Y; Maeda, I; Matsuda, Y; Matsuoka, H; Osaka, I; Tsuneto, S; Wagatsuma, Y; Watanabe, H; Yamaguchi, T	1
Beeker, A; Berkhof, J; Neefjes, ECW; Rhodius, CA; Ten Oever, D; van den Berg, HP; van der Vliet, HJ; van der Vorst, MJDL; van der Wijngaart, H; Verheul, HMW	1
Matsuda, Y; Matsunuma, R; Mori, M; Suzuki, K; Watanabe, H; Yamaguchi, T	1
Leppert, W; Nosek, K	1
Bianchi, A; Bramati, A; Carbone, C; Farina, G; Febbraro, A; Ganzinelli, M; Garassino, MC; Gentili, M; Iorno, V; La Verde, N; Marabese, M; Moretti, A; Piva, S; Spagnoletti, I; Torri, V	1
Ishida, T; Kawakami, J; Naito, T; Ohnishi, K; Tashiro, M	1
Earl, CQ; Narayana, A; Slevin, KA; Webster, LR; Yang, R	1
Baek, JH; Baek, SK; Cho, DY; Choi, YJ; Kim, SY; Ryoo, HM; Shin, HW; Song, HS; Zang, DY	1
Anderson, H; Charles, B; George, R; Hardy, J; Norris, R; Tapuni, A	1
Connola, M; Cuomo, A; Esposito, G; Forte, CA; Marcassa, C; Russo, G	1
Kagawa, Y; Kawakami, J; Naito, T; Ohnishi, K; Tashiro, M	1
Fayers, P; Fladvad, T; Kaasa, S; Klepstad, P; Skorpen, F	1
Carroll, E; Conroy, L; Curran, HV; Jones, L; Kamboj, SK; Tookman, A	1
Hosokawa, T; Kanbayashi, Y	1
Han, J; Hou, Y; Richards, HM; Shen, W; Yu, L; Yu, S	1
Derry, S; Moore, RA; Wiffen, PJ	1
Branford, R; Droney, J; Gretton, S; Kennett, A; Oyebode, C; Riley, J; Ross, J; Sato, H; Thick, M; Wells, A; Welsh, K; Williams, J	1
Chittams, J; Fudin, J; Kang, Y; Mao, JJ; McMenamin, E; Meghani, SH	1
Chayahara, N; Fujiwara, Y; Imamura, Y; Kiyota, N; Minami, H; Mukohara, T; Shimada, T; Toyoda, M	1
Ahmedzai, SH; Duerr, H; Hopp, M; Janecki, M; Leppert, W; Lomax, M; Pakosz, A	1
Gunnar, T; Heiskanen, T; Kalso, EA; Langel, K; Lillsunde, P	1
De Andrés, J; Koopmans, G; Lux, EA; Simpson, K; Van Megen, Y; Wagemans, M	1
Fukumura, K; Hojo, M; Kokubun, H; Matoba, M; Yoshimoto, T	1
He, BX; Yu, WJ; Zhang, WZ; Zhao, XL	1
Kawagoe, I; Sasaki, T	1
Ca, LH; Chang, J; Huang, XE; Huang, XH; Liu, J; Ma, YM; Wei, W; Wu, YJ; Xiao, Y; Zhang, RX	1
Arakawa, Y; Fukuura, K; Futamura, A; Hayashi, T; Higashiguchi, T; Ikehata, S; Kuki, R; Makihara, T; Matsuzaki, H; Mori, N; Takahashi, H; Yamadaa, S; Yasuda, K	1
Goda, Y; Kamiyama, H; Oda, K	1
Hermanns, K; Hesselbarth, S; Oepen, P	1
Abe, K; Hasuo, H; Ichida, Y; Igarashi, T; Kinoshita, H; Matsumoto, Y; Miura, T; Motonaga, S; Saito, S; Tagami, K	1
Kawakami, J; Naito, T	1
Aoki, Y; Kanazawa, Y; Uchida, E; Yamada, T	1
Csikós, Á; Kullmann, T; Pintér, T; Sipőcz, I	1
Higashi, T; Iwamoto, M; Kawaguchi, T; Matoba, M; Miura, H; Tanaka, S; Yamashita, I; Yoshida, S; Yoshimoto, T	1
Caldarulo, C; Corli, O; Finocchi, S; Greco, MT; Lazzari, M; Marcassa, C	1
Apolone, G; Azzarello, G; Bandieri, E; Caraceni, A; Cavanna, L; Corli, O; Crispino, C; Di Gregorio, R; Dragani, TA; Floriani, I; Galli, F; Gamucci, T; Greco, MT; Iorno, V; Kaasa, S; Lipari, G; Luzzani, M; Montanari, M; Pacchioni, M; Pavesi, L; Reale, C; Roberto, A; Valenti, D	1
Ishikawa, H; Matsumoto, T; Mori, K; Omae, K; Osaka, I; Sato, T; Shino, M; Tanaka, R	1
Huang, L; Jin, SH; Liu, Y; Ma, H; Tian, X; Yue, GJ; Zeng, XT; Zhou, JG	1
Hayakawa, T; Maeda, T	1
Cheng, XJ; Guan, BQ; Hao, JL; Ji, K; Liu, WS; Shao, YJ; Wang, K	1
Ishida, T; Kawakami, J; Naito, T; Sato, H	1
Choy, LW; Ismail, CR; Rahman, NA; Zin, CS	1
Bao, YJ; Hou, W; Hua, BJ; Knaggs, R; Kong, XY; Xia, J; Yang, L	1
Gajria, KL; Harshaw, Q; Katz, NP; Shillington, AC; Stephenson, JJ	1
Aitini, E; Bandieri, E; Calorio, A; Dambrosio, M; Del Prete, S; Endrizzi, L; Garetto, F; Ianniello, GP; Marra, A; Micheletto, G; Nastasi, G; Piantedosi, F; Sabbatini, G; Sidoti, V; Silvestri, B; Spanu, P	1
Yu, SY	1
Fan, BF	1
Ong, EC	1
Núñez Olarte, JM	1
Gómez Sancho, M; Martín, MO; Morlion, B; Simpson, K	1
Bandieri, E; Chiarolanza, A; Luppi, M; Magrini, N; Marata, AM; Ripamonti, C	1
Quigley, C	1
Hasegawa, T; Hisada, A; Matoba, M; Nozaki, Y; Yoshimoto, T	1
Ahn, JS; Kim, DY; Kim, SY; Ryoo, BY; Shin, DB; Song, HS; Yim, CY	1
Hasegawa, T; Hisada, A; Matoba, M; Murakami, S; Tomiyasu, S; Yomiya, K; Yoshimoto, T	1
Casuccio, A; David, F; Ferrera, P; Mercadante, S	1
Ciria Santos, JP; Cobo Dols, M; Cumplido Burón, JD; de Castro Carpeño, FJ; Del Moral González, F; Enrech Francés, S; Esteban González, E; García de Paredes, ML; Gascó Hernández, A; López Miranda, E; Majem Tarruella, M; Martí Ciriquián, JL; Martínez Del Prado, P; Ortega Granados, AL	1
Jarlbaek, L; Kehlet, H; Sjøgren, P	1
Andreassen, TN; Bjordal, K; Dale, O; Davies, A; Kaasa, S; Klepstad, P; Lundström, S	2
Kagawa, Y; Kawakami, J; Naito, T; Ohnishi, K; Takashina, Y; Tashiro, M; Yamamoto, K	1
Kokubun, H; Matoba, M; Yago, K; Yamada, Y	1
Clemens, KE; Klaschik, E; Quednau, I	1
Fujimoto, S; Hosokawa, T; Kanbayashi, Y; Konishi, H; Miki, T; Okamoto, K; Otsuji, E; Takagi, T; Taniwaki, M; Yoshikawa, T	1
Anderson, H; Charles, B; Hardy, J; Norris, R; O'Shea, A	1
Sumitani, M; Yamada, Y	1
Forbes, K; Hanks, G; King, SJ; Reid, C	1
Andreassen, TN; Bjordal, K; Dale, O; Davies, A; Eftedal, I; Kaasa, S; Klepstad, P; Lundström, S	1
Dale, O; Kaasa, S; Klepstad, P; Moksnes, K; Paulsen, O; Rosland, JH	1
Awerbuch, MS	1
Adile, C; Casuccio, A; Ferrera, P; Mercadante, S; Villari, P	1
Kutner, JS; Linnebur, SA; O'Bryant, CL; Yamashita, TE	1
Ahmedzai, SH; Bar-Sela, G; Bosse, B; Hopp, M; Leyendecker, P; Nauck, F	1
Alvarez-Jiménez, P; Núñez-Olarte, JM	1
Cherry, DA; Cornish, PB; Kapur, D; Snellgrove, CA	1
Araki, H; Ikesue, H; Ishihara, M; Itoh, Y; Kitaichi, K; Matsunaga, H; Oishi, R; Sendo, T; Suemaru, K; Suetsugu, K	1
Mercadante, S	2
Dale, O; Kaasa, S; Moksnes, K; Paulsen, Ø; Rosland, JH; Spigset, O	1
Fujio, N; Ishikawa, N; Kameyama, M; Watanabe, H; Yamazaki, K	1
Cousins, MJ	1
Kagawa, Y; Kawakami, J; Naito, T; Ohnishi, K; Tashiro, M; Yamamoto, K	1
Akagi, T; Kudo, N; Matoba, M; Miura, K; Murakami, S; Saito, O; Sano, T; Shuto, C; Yamamoto, H; Yokote, N	1
Kaneishi, K; Kawabata, M	1
Kokubun, H; Komatsu, T; Matoba, M; Suzuki, A; Takayanagi, R; Yago, K; Yamada, Y	1
Gotoh, K; Sakurada, T; Satoh, N; Suzuki, M; Watanabe, S	1
Doi, M; Nitta, T; Shinozaki, K; Yamauchi, M	1
Taeron, C	1
Davis, MP; Dickerson, D; Lagman, R; LeGrand, SB; Varga, J; Walsh, D	1
Gallagher, RM; Gracely, E; Hall, S; Knowlton, C; Wescules, D	1
HUNNYBUN, J; STATHERS, DN	1
Lauretti, GR; Oliveira, GM; Pereira, NL	1
Weinman, BP	1
McCaffery, M; Pasero, C	1
Berger, A; Delea, TE; Goodman, S; Hoffman, DL; Oster, G; Seifeldin, R	1
Borchgrevink, PC; Kaasa, S; Klepstad, P; Kongsgaard, UE	1
Katz, RT	1
Ahdieh, H; Dvergsten, C; Gabrail, NY	1
Stiehl, M	1
Fiore, LD; Gagnon, DR; Hermos, JA; Young, MM	1
Araki, N; Hasegawa, H; Hatanaka, K; Hiraga, K; Katayama, K; Kawahara, M; Kimura, H; Kodama, K; Koizumi, W; Kono, I; Matsui, K; Takeda, F; Takiuchi, H; Toma, H; Watanabe, K; Yoshino, K	1
Walsh, D	1
Hattori, S; Kimura, N; Noguchi, T; Takatani, J	1
Hori, N; Konishi, T	1
Hanks, GW; Reid, C	1
Hoka, S; Kokubun, H; Kubo, H; Matoba, M; Ouki, M; Yago, K	1
Kalso, E	1
du Bois, R; Goller, K; Riley, J; Ross, JR; Rutter, D; Wells, AU; Welsh, K	1
Narita, M; Niikura, K; Ozaki, M; Suzuki, T; Yajima, Y	1
Davies, AN; Hanks, GW; Martin, RM; Reid, CM; Sterne, JA	1
Comfort, C; Kogan, M; Moryl, N; Obbens, E	1
Hoka, S; Kokubun, H; Komatsu, T; Matoba, M; Nakamura, K; Yago, K	1
Fukawa, M; Hoka, S; Kokubun, H; Matoba, M; Yago, K; Yamada, Y	1
Arendt-Nielsen, L; Drewes, AM; Eisenberg, E; Müller-Schwefe, G; Riley, J	1
Gooberman-Hill, R; Hanks, GW; Reid, CM	1
Fukawa, M; Hoka, S; Kokubun, H; Matoba, M; Nakamura, K; Yago, K	1
Chida, M; Hosokawa, T; Kamoto, T; Miura, T; Narabayashi, M; Nishimura, K; Onozawa, Y; Saijo, Y; Shimoyama, N; Takenoshita, S; Tani, K; Tsushima, T	1
Hanaoka, K; Hosokawa, T; Ishida, T; Kitajima, T; Mashimo, S; Miyazaki, T; Namiki, A; Nogami, S; Ogawa, S	1
Bruera, E; Hanson, J; Pereira, J; Tarumi, Y; Watanabe, S	1
Stambaugh, JE; Tejada, F; Trudnowski, RJ	1
Cramond, T; Leow, KP; Smith, MT	1
Glare, PA; Walsh, TD	1
Babul, N; Hagen, NA	1
Heiskanen, T; Kalso, E	1
Babul, N; Belzile, M; Bruera, E; Darke, A; Fainsinger, R; Ford, I; Harsanyi, Z; Pituskin, E	1
Buckley, BJ; Citron, ML; Kaiko, RF; Kaplan, R; Parris, WC; Reder, RF; Zhukovsky, D	1
Buckley, BJ; Croghan, MK; Johnson, BW; Kaiko, RF; Khojasteh, A; Moore, MR; Parris, WC; Reder, RF	1
Buckley, BJ; Citron, ML; Croghan, MK; Herbst, LH; Kaiko, RF; Kaplan, R; Parris, WC; Reder, RF; Rosenbluth, RJ; Slagle, NS	1
Ashby, MA; Jackson, KA; Martin, P	1
Bielech, M; Bruera, E; Gagnon, B; Hanson, J; Walker, P; Watanabe, S	1
Heiskanen, TE; Kalso, EA; Ruismäki, PM; Seppälä, TA	1
Casas, JR; Cherny, N; Conno, F; Hanks, GW; Hanna, M; Kalso, E; McQuay, HJ; Mercadante, S; Meynadier, J; Poulain, P; Radbruch, L; Ripamonti, C; Sawe, J; Twycross, RG; Ventafridda, V	1
Davis, M; Reder, RF; Stambaugh, H; Stambaugh, JE; Stambaugh, MD	1
de Wit, R; Enting, RH; Lieverse, PJ; Smitt, PA; van der Rijt, CC; Wilms, EB	1
Carroll-Johnson, RM	1
Cairns, R	1
Beaver, WT; Houde, RW; Rogers, A; Wallenstein, SL	2
Cramond, T; Leow, KP; Smith, MT; Williams, B	1
Kalso, E; Mattila, MJ; Rosenberg, PH; Seppälä, T; Vainio, A	1
Kalso, E; Vainio, A	1

Reviews

32 review(s) available for oxycodone and Benign Neoplasms

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
Use of opioids in patients with cancer with hepatic impairment-a systematic review. BMJ supportive & palliative care, 2022, Volume: 12, Issue:2 Topics: Adolescent; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Neoplasms; Oxycodone	2022
Oxycodone for cancer-related pain. The Cochrane database of systematic reviews, 2022, 06-09, Volume: 6 Topics: Adult; Analgesics, Opioid; Cancer Pain; Constipation; Humans; Morphine; Nausea; Neoplasms; Oxycodone; Pain; Quality of Life; Reproducibility of Results; Sleepiness; Vomiting	2022
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. The Cochrane database of systematic reviews, 2022, 09-15, Volume: 9 Topics: Adult; Analgesics, Opioid; Child; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Oxycodone; Palliative Care; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome	2022
Tapentadol for the management of cancer pain in adults: an update. Current opinion in supportive and palliative care, 2023, 06-01, Volume: 17, Issue:2 Topics: Adult; Analgesics; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Multicenter Studies as Topic; Neoplasms; Oxycodone; Pain; Phenols; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Opioid; Tapentadol	2023
Oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: Challenges in the context of hepatic impairment. Asia-Pacific journal of clinical oncology, 2022, Volume: 18, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Constipation; Delayed-Action Preparations; Humans; Liver Diseases; Naloxone; Neoplasms; Oxycodone; Tablets	2022
Hydromorphone for cancer pain. The Cochrane database of systematic reviews, 2021, 08-05, Volume: 8 Topics: Adult; Analgesics, Opioid; Cancer Pain; Child; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone	2021
Oxycodone for cancer-related pain. The Cochrane database of systematic reviews, 2017, 08-22, Volume: 8 Topics: Aged; Analgesics, Opioid; Cancer Pain; Constipation; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morphine; Nausea; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Randomized Controlled Trials as Topic; Sleep Stages; Vomiting	2017
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain. Clinical drug investigation, 2017, Volume: 37, Issue:12 Topics: Adult; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Diarrhea; Drug Combinations; Gastrointestinal Tract; Humans; Naloxone; Nausea; Neoplasms; Oxycodone	2017
Opioid Rotation in Cancer Pain Treatment. Deutsches Arzteblatt international, 2018, 03-02, Volume: 115, Issue:9 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management	2018
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. The Cochrane database of systematic reviews, 2018, 06-05, Volume: 6 Topics: Constipation; Defecation; Female; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Piperidines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Receptors, Opioid, mu	2018
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. The Cochrane database of systematic reviews, 2014, May-29, Issue:5 Topics: Analgesics, Opioid; Appetite; Codeine; Consciousness; Fentanyl; Humans; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic; Terminal Care; Thirst	2014
Oxycodone for cancer-related pain. The Cochrane database of systematic reviews, 2015, Feb-27, Issue:2 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Humans; Morphine; Neoplasms; Oxycodone; Pain; Pain Management; Randomized Controlled Trials as Topic	2015
[Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015, Volume: 135, Issue:5 Topics: Analgesics, Opioid; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug Substitution; Drug Tolerance; Fentanyl; Genetic Variation; Humans; Neoplasms; Oxycodone; Pain, Intractable; Palliative Care; Pharmacogenetics; Precision Medicine	2015
[New option in the management of cancer pain in Hungary: short acting oral opioid therapy]. Orvosi hetilap, 2015, Jun-21, Volume: 156, Issue:25 Topics: Administration, Oral; Analgesics, Opioid; Analgesics, Short-Acting; Drug Administration Schedule; Drug Approval; Fentanyl; Humans; Hungary; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Therapeutic Equivalency; Time Factors	2015
The Adverse Events of Oxycodone in Cancer-Related Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine, 2016, Volume: 95, Issue:15 Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic	2016
Hydromorphone for cancer pain. The Cochrane database of systematic reviews, 2016, Oct-11, Volume: 10 Topics: Adult; Analgesics, Opioid; Female; Humans; Hydromorphone; Male; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Randomized Controlled Trials as Topic	2016
Oxycodone and the challenge of neuropathic cancer pain: a review. Oncology, 2008, Volume: 74 Suppl 1 Topics: Analgesics, Opioid; Humans; Neoplasms; Neuralgia; Oxycodone; Randomized Controlled Trials as Topic	2008
Opioids in people with cancer-related pain. BMJ clinical evidence, 2008, Jul-31, Volume: 2008 Topics: Administration, Oral; Analgesics; Analgesics, Opioid; Codeine; Fentanyl; Humans; Methadone; Neoplasms; Oxycodone; Pain	2008
[The licit opioid consumption in Denmark]. Ugeskrift for laeger, 2010, Nov-15, Volume: 172, Issue:46 Topics: Analgesics, Opioid; Buprenorphine; Databases, Factual; Denmark; Drug Costs; Drug Utilization; Fentanyl; Humans; Neoplasms; Oxycodone; Pain; Substance-Related Disorders	2010
[Solutions for the clinical problems of analgesics for cancer pain treatment in Japan]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:1 Topics: Acetaminophen; Analgesics; Drug Administration Routes; Fentanyl; Humans; Japan; Neoplasms; Oxycodone; Pain; Palliative Care	2011
A systematic review of oxycodone in the management of cancer pain. Palliative medicine, 2011, Volume: 25, Issue:5 Topics: Analgesics, Opioid; Europe; Humans; Neoplasms; Oxycodone; Pain; Pain Measurement; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Severity of Illness Index	2011
Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:2 Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Liver Failure; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care; Sex Factors; Uremia	2003
Controlled-release oxycodone. The American journal of nursing, 2004, Volume: 104, Issue:1 Topics: Acute Disease; Analgesics, Opioid; Chemistry, Pharmaceutical; Chronic Disease; Delayed-Action Preparations; Humans; Neoplasms; Oxycodone; Pain; Pain Measurement; Substance-Related Disorders; Treatment Outcome	2004
Advances in opioid therapy and formulations. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:3 Topics: Administration, Cutaneous; Analgesia, Patient-Controlled; Analgesics, Opioid; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Infusion Pumps, Implantable; Male; Morphine; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Risk Assessment; Sensitivity and Specificity; Treatment Outcome	2005
Contribution to variability in response to opioids. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:3 Topics: Analgesics, Opioid; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Hydromorphone; Male; Maximum Tolerated Dose; Morphine; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome	2005
Oxycodone. Journal of pain and symptom management, 2005, Volume: 29, Issue:5 Suppl Topics: Analgesics, Opioid; Animals; Biological Availability; Drug Interactions; History, 20th Century; Humans; Liver Failure; Neoplasms; Oxycodone; Pain; Pain, Postoperative; Renal Insufficiency	2005
[Basic studies on cancer pain control]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10 Topics: Analgesics, Opioid; Animals; Constipation; Dose-Response Relationship, Drug; Fentanyl; Humans; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Vomiting; World Health Organization	2005
Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Archives of internal medicine, 2006, Apr-24, Volume: 166, Issue:8 Topics: Analgesics, Opioid; Humans; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic; Treatment Outcome	2006
Oxycodone: a review of its use in the management of pain. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Age Factors; Analgesics, Opioid; Animals; Diabetic Neuropathies; Drug Evaluation; Humans; Immune Tolerance; Liver Failure; Metabolic Clearance Rate; Neoplasms; Oxycodone; Pain; Receptors, Opioid, mu; Renal Insufficiency; Sex Characteristics; Treatment Outcome	2008
[Treatment of pain in cancer with systemically administered opioids]. Nederlands tijdschrift voor geneeskunde, 2001, May-19, Volume: 145, Issue:20 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Humans; Infusion Pumps; Methadone; Morphine; Neoplasms; Netherlands; Oxycodone; Pain; Palliative Care; Practice Guidelines as Topic; World Health Organization	2001
The use of oxycodone in cancer-related pain: a literature review. International journal of palliative nursing, 2001, Volume: 7, Issue:11 Topics: Analgesics, Opioid; Drug Administration Schedule; Evidence-Based Medicine; Hallucinations; Humans; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Patient Selection; Research Design; Sample Size; Therapeutic Equivalency; Treatment Outcome	2001

Trials

54 trial(s) available for oxycodone and Benign Neoplasms

Article	Year
Sleep and vigilance, 2022, Volume: 6, Issue:2 Topics: Aged; Algorithms; Anesthesia, General; Artificial Intelligence; Autophagy; Beclin-1; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cough; Cross Infection; Delirium; Diffusion Magnetic Resonance Imaging; Glucose; Hematocrit; Hemoglobins; Histone Deacetylase 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I-kappa B Proteins; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Oxycodone; Patient Comfort; Physical Examination; Prognosis; Prospective Studies; Quality of Life; Retrospective Studies; RNA, Messenger; Signal Transduction; Skin Neoplasms; Stroke Volume; Sufentanil; Survival Rate; Ventricular Function, Left; Vomiting	2022
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study). The oncologist, 2023, 03-17, Volume: 28, Issue:3 Topics: Analgesics, Opioid; Biomarkers; Cancer Pain; Catechol O-Methyltransferase; Genotype; Humans; Morphine; Neoplasms; Oxycodone; Pain	2023
A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Humans; Morphine; Neoplasms; Oxycodone; Quality of Life	2021
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life	2017
Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study). BMC cancer, 2017, Oct-06, Volume: 17, Issue:1 Topics: Analgesics, Opioid; Biomarkers, Tumor; Cancer Pain; Catechol O-Methyltransferase; Female; Humans; Male; Morphine; Neoplasms; Oxycodone; Pain Management; Polymorphism, Single Nucleotide	2017
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients. Japanese journal of clinical oncology, 2018, Jun-01, Volume: 48, Issue:6 Topics: Aged; Analgesics, Opioid; Asian People; Cancer Pain; Delayed-Action Preparations; Demography; Depression; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Neoplasms; Oxycodone; Pain Measurement; Powders; Tablets; Treatment Outcome	2018
Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl. Current pharmaceutical design, 2019, Volume: 25, Issue:30 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Delayed-Action Preparations; Female; Fentanyl; Humans; Male; Morphine; Neoplasms; Oxycodone; Quality of Life	2019
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PloS one, 2013, Volume: 8, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Polymorphism, Single Nucleotide; Pregabalin; Treatment Outcome	2013
Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients. Journal of clinical pharmacology, 2013, Volume: 53, Issue:8 Topics: Aged; Analgesics, Opioid; Cachexia; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain	2013
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:9 Topics: Administration, Buccal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain Management; Patient Satisfaction; Treatment Outcome; Young Adult	2013
Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS). BMJ supportive & palliative care, 2012, Volume: 2, Issue:4 Topics: Analgesics, Opioid; Cohort Studies; Europe; Female; Fentanyl; Genetic Association Studies; Genetic Variation; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Treatment Outcome	2012
Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids. European journal of pain (London, England), 2014, Volume: 18, Issue:10 Topics: Affect; Aged; Analgesics, Opioid; Breakthrough Pain; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Memory; Mental Recall; Middle Aged; Morphine; Neoplasms; Neuropsychological Tests; Oxycodone; Pain	2014
Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study. The journal of pain, 2014, Volume: 15, Issue:8 Topics: Adolescent; Adult; Aged; Analgesics, Opioid; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Sample Size; Treatment Outcome; Young Adult	2014
Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial. Journal of pain and symptom management, 2015, Volume: 49, Issue:2 Topics: Analgesics, Opioid; Cross-Over Studies; Drug Substitution; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Prospective Studies; Treatment Outcome	2015
Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients. PloS one, 2014, Volume: 9, Issue:8 Topics: Adult; Aged; Analgesics, Opioid; Aprepitant; Area Under Curve; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Morpholines; Neoplasms; Oxycodone; Oxymorphone; Pain	2014
Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:3 Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life; Severity of Illness Index; Tablets; Treatment Outcome	2015
Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives. Current medical research and opinion, 2014, Volume: 30, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Treatment Outcome	2014
Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain. Journal of pain & palliative care pharmacotherapy, 2014, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Asian People; Humans; Infusions, Intravenous; Infusions, Subcutaneous; Male; Middle Aged; Neoplasms; Oxycodone; Pain	2014
Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Neoplasms; Oxycodone; Pain; Pain Measurement; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2014
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:6 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone	2016
Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study. Clinical drug investigation, 2008, Volume: 28, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Italy; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Prospective Studies; Quality of Life; Severity of Illness Index	2008
Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain. Oncology, 2008, Volume: 74 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Drug Utilization; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Palliative Care; Product Surveillance, Postmarketing; Prospective Studies; Tablets; Treatment Outcome	2008
Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain. Oncology, 2008, Volume: 74 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia, Postherpetic; Oxycodone; Pain Measurement; Product Surveillance, Postmarketing; Prospective Studies; Tablets	2008
Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients. European journal of clinical pharmacology, 2011, Volume: 67, Issue:5 Topics: Analgesics, Opioid; Cross-Sectional Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain; Sex Factors	2011
CYP3A53 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone. Journal of clinical pharmacology, 2011, Volume: 51, Issue:11* Topics: Aged; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Polymorphism, Genetic; Receptors, Opioid, mu	2011
Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. International journal of clinical practice, 2011, Volume: 65, Issue:4 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Tablets	2011
How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:16 Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Substitution; Female; Humans; Male; Methadone; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Patient Dropouts; Prospective Studies	2011
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliative medicine, 2012, Volume: 26, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Quality of Life	2012
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain. European journal of clinical pharmacology, 2012, Volume: 68, Issue:8 Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methadone; Middle Aged; Morphine; Morphine Derivatives; Neoplasms; Oxycodone; Pain; Palliative Care; Patient Dropouts	2012
[Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Time Factors	2012
Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study. The American journal of hospice & palliative care, 2013, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Dyspnea; Female; Humans; Infusions, Subcutaneous; Male; Middle Aged; Neoplasms; Oxycodone; Pain Management; Retrospective Studies; Terminal Care; Treatment Outcome	2013
Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. British journal of cancer, 2003, Dec-01, Volume: 89, Issue:11 Topics: Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Time Factors	2003
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Current medical research and opinion, 2004, Volume: 20, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Oxymorphone; Pain; United States	2004
Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:10 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Patient Acceptance of Health Care; Stomach Neoplasms; Tablets; Titrimetry	2004
Methadone in the treatment of pain and terminal delirum in advanced cancer patients. Palliative & supportive care, 2005, Volume: 3, Issue:4 Topics: Aged; Analgesics, Opioid; Delirium; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methadone; Middle Aged; Morphine; Neoplasms; Neuropsychological Tests; Oxycodone; Pain; Pain Measurement; Palliative Care; Treatment Outcome	2005
Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. Japanese journal of clinical oncology, 2008, Volume: 38, Issue:4 Topics: Administration, Oral; Aged; Analgesics, Opioid; Constipation; Drug Administration Schedule; Female; Humans; Linear Models; Male; Middle Aged; Morphinans; Morphine; Morphine Derivatives; Nausea; Neoplasms; Oxycodone; Pain; Prospective Studies; Renal Insufficiency, Chronic; Sleep Stages; Treatment Outcome; Vomiting	2008
Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain. Clinical drug investigation, 2008, Volume: 28, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Endpoint Determination; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement	2008
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. Journal of palliative medicine, 2008, Volume: 11, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Health Status Indicators; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement	2008
Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain. Journal of clinical pharmacology, 1980, Volume: 20, Issue:4 Topics: Adult; Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Neoplasms; Oxycodone; Pain; Phenacetin; Pyrroles; Tolmetin	1980
Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesthesia and analgesia, 1995, Volume: 80, Issue:2 Topics: Administration, Rectal; Aged; Analgesia; Female; Humans; Injections, Intravenous; Male; Neoplasms; Oxycodone; Pain	1995
Dose-ranging study of oxycodone for chronic pain in advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Prospective Studies	1993
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer, 1997, Apr-01, Volume: 79, Issue:7 Topics: Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain	1997
Controlled-release oxycodone and morphine in cancer related pain. Pain, 1997, Volume: 73, Issue:1 Topics: Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain	1997
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement	1998
Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Patient Acceptance of Health Care	1998
The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study. Journal of pain and symptom management, 1998, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; United States	1998
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain. Cancer investigation, 1998, Volume: 16, Issue:8 Topics: Administration, Oral; Adult; Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Patient Acceptance of Health Care; Time Factors	1998
The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:4 Topics: Adult; Aged; Analgesics, Opioid; Analysis of Variance; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Patient Satisfaction; Prospective Studies; Treatment Outcome	1999
Morphine or oxycodone in cancer pain? Acta oncologica (Stockholm, Sweden), 2000, Volume: 39, Issue:8 Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Debrisoquin; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Morphinans; Morphine; Morphine Derivatives; Neoplasms; Oxycodone; Pain; Pain Measurement; Phenotype	2000
Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients. Journal of clinical pharmacology, 2001, Volume: 41, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Biological Availability; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Pain; Pain Measurement; Therapeutic Equivalency; Vomiting	2001
Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. The Journal of pharmacology and experimental therapeutics, 1978, Volume: 207, Issue:1 Topics: Adult; Aged; Analgesics; Clinical Trials as Topic; Codeine; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain	1978
Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. The Journal of pharmacology and experimental therapeutics, 1978, Volume: 207, Issue:1 Topics: Administration, Oral; Adult; Aged; Analgesics; Clinical Trials as Topic; Codeine; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Time Factors	1978
Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. Pharmacology & toxicology, 1990, Volume: 67, Issue:4 Topics: Administration, Oral; Analgesia, Patient-Controlled; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Morphine; Neoplasms; Oxycodone; Pain; Radioligand Assay	1990
Morphine and oxycodone hydrochloride in the management of cancer pain. Clinical pharmacology and therapeutics, 1990, Volume: 47, Issue:5 Topics: Administration, Oral; Adult; Aged; Codeine; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic	1990

Other Studies

101 other study(ies) available for oxycodone and Benign Neoplasms

Article	Year
Drug-Drug Interactions Associated with Introduction of Oxycodone for Management of Cancer-Related Pain in Hospitalized Patients. Journal of palliative medicine, 2021, Volume: 24, Issue:9 Topics: Analgesics, Opioid; Cancer Pain; Delayed-Action Preparations; Drug Interactions; Humans; Neoplasms; Oxycodone; Pharmaceutical Preparations	2021
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol	2021
Prevalence of opioid prescriptions in Taiwan (2008-2018). Journal of the Chinese Medical Association : JCMA, 2022, 05-01, Volume: 85, Issue:5 Topics: Analgesics, Opioid; Chronic Pain; Drug Prescriptions; Humans; Meperidine; Morphine; Neoplasms; Oxycodone; Prevalence; Taiwan; United States	2022
Trends in strong opioid prescription for cancer patients in Japan from 2010 to 2019: an analysis with large medical claims data. Japanese journal of clinical oncology, 2022, Nov-03, Volume: 52, Issue:11 Topics: Aged; Analgesics, Opioid; Drug Prescriptions; Fentanyl; Humans; Infant; Japan; Morphine; Neoplasms; Oxycodone; Practice Patterns, Physicians'; Prescriptions	2022
Post-mortem oxycodone blood concentrations of hospitalized cancer and surgery patients compared with fatal poisonings. International journal of legal medicine, 2022, Volume: 136, Issue:6 Topics: Analgesics, Opioid; Autopsy; Humans; Neoplasms; Oxycodone; Substance-Related Disorders	2022
Rapid Titration With Intravenous Oxycodone for Severe Cancer Pain and Oral Conversion Ratio. Journal of pain and symptom management, 2022, Volume: 64, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Humans; Neoplasms; Oxycodone; Pain	2022
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study. Journal of pain and symptom management, 2023, Volume: 65, Issue:5 Topics: Adult; Analgesics, Opioid; Drug Tolerance; Dyspnea; Humans; Morphine; Neoplasms; Oxycodone	2023
Evidence Regarding Pharmacogenetics in Pain Management and Cancer. The oncologist, 2023, 03-17, Volume: 28, Issue:3 Topics: Analgesics, Opioid; Cancer Pain; Catechol O-Methyltransferase; Cytochrome P-450 CYP2D6; Genotype; Humans; Morphine; Neoplasms; Oxycodone; Pain Management; Pharmacogenetics	2023
Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023, Mar-13, Volume: 31, Issue:4 Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Humans; Neoplasms; Neurotoxicity Syndromes; Oxycodone; Pregabalin; Retrospective Studies; Risk Factors	2023
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. Journal of pain and symptom management, 2023, Volume: 66, Issue:2 Topics: Aged; Analgesics, Opioid; Cohort Studies; Dyspnea; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone	2023
[Drug therapy for cancer-related pain-evidence regarding hydromorphone, oxycodone, and methadone : Presentation and summary of three Cochrane reviews]. Urologie (Heidelberg, Germany), 2023, Volume: 62, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Methadone; Neoplasms; Oxycodone	2023
Oxycodone Extended-Release Capsule Utilization for Pain Management in a Cancer Palliative Care Clinic: A Retrospective Review. Journal of pain & palliative care pharmacotherapy, 2023, Volume: 37, Issue:4 Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Neoplasms; Oxycodone; Pain; Pain Management; Palliative Care; Retrospective Studies	2023
Potential Drug Interactions in Terminally-Ill Cancer Patients, a Report from the Middle East. Journal of pain & palliative care pharmacotherapy, 2023, Volume: 37, Issue:4 Topics: Cross-Sectional Studies; Drug Interactions; Humans; Middle East; Neoplasms; Oxycodone; Sertraline	2023
Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain. Biological & pharmaceutical bulletin, 2023, Volume: 46, Issue:10 Topics: Administration, Cutaneous; Analgesics; Analgesics, Opioid; Cancer Pain; Fentanyl; Humans; Neoplasms; Oxycodone	2023
Both Race and Insurance Type Independently Predict the Selection of Oral Opioids Prescribed to Cancer Outpatients. Pain management nursing : official journal of the American Society of Pain Management Nurses, 2020, Volume: 21, Issue:1 Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Cancer Pain; Female; Humans; Insurance Coverage; Logistic Models; Male; Middle Aged; Morphine; Neoplasms; Outpatients; Oxycodone; Racial Groups	2020
Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain. Japanese journal of clinical oncology, 2019, Dec-18, Volume: 49, Issue:11 Topics: Administration, Intravenous; Adult; Aged; Analgesics, Opioid; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Management; Pain Measurement; Retrospective Studies	2019
The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells. Bioscience reports, 2020, 02-28, Volume: 40, Issue:2 Topics: Analgesics, Opioid; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caco-2 Cells; Cell Movement; Cell Proliferation; Drug Interactions; ErbB Receptors; Humans; Neoplasm Invasiveness; Neoplasms; Oxidative Stress; Oxycodone; Signal Transduction	2020
[Analysis of Symptoms Relieved in Addition to Pain after Administration of Oxycodone or Morphine to Patients with Advanced Cancer Living at Home]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:5 Topics: Administration, Cutaneous; Analgesics, Opioid; Cancer Pain; Fentanyl; Humans; Morphine; Neoplasms; Oxycodone; Pain	2020
Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study. Asia-Pacific journal of clinical oncology, 2021, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Naloxone; Neoplasms; Oxycodone; Retrospective Studies	2021
[Hydromorphone in Cancer Patients-A Retrospective Study]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:12 Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Oxycodone; Retrospective Studies	2020
Managing an intentional overdose in a hospice. BMJ supportive & palliative care, 2018, Volume: 8, Issue:2 Topics: Advance Directives; Aged; Drug Overdose; Female; Hospice Care; Humans; Neoplasms; Oxycodone; Palliative Care; Suicide, Attempted	2018
The impact of UGT2B7 C802T and CYP3A41G polymorphisms on pain relief in cancer patients receiving oxycontin. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:8* Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Polymorphism, Single Nucleotide; Young Adult	2018
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication. Drugs in R&D, 2018, Volume: 18, Issue:2 Topics: Administration, Sublingual; Aged; Analgesics, Opioid; Breakthrough Pain; Drug Combinations; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Naloxone; Neoplasm Staging; Neoplasms; Oxycodone; Pain Management; Quality of Life; Treatment Outcome	2018
Effect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspnea. Japanese journal of clinical oncology, 2018, Aug-01, Volume: 48, Issue:8 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Dyspnea; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Quality of Life; Retrospective Studies; Treatment Outcome	2018
Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study. Medical science monitor : international medical journal of experimental and clinical research, 2018, Sep-19, Volume: 24 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; China; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Quality of Life; Retrospective Studies; Self Report; Treatment Outcome	2018
Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trial. Japanese journal of clinical oncology, 2018, Dec-01, Volume: 48, Issue:12 Topics: Adult; Aged; Analgesics, Opioid; Dyspnea; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone	2018
Optimal treatment of opioid induced constipation in daily clinical practice - an observational study. BMC palliative care, 2019, Mar-29, Volume: 18, Issue:1 Topics: Aged; Analgesics, Opioid; Constipation; Female; Fentanyl; Humans; Laxatives; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neoplasms; Oxycodone; Pain Management; Prospective Studies; Quaternary Ammonium Compounds; Retrospective Studies; Surveys and Questionnaires	2019
The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians. Journal of pain and symptom management, 2019, Volume: 58, Issue:4 Topics: Analgesics, Opioid; Dyspnea; Fentanyl; Humans; Japan; Morphine; Neoplasms; Oxycodone; Palliative Care; Patient Selection; Practice Patterns, Physicians'; Surveys and Questionnaires	2019
Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics. Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:12 Topics: Adult; Aged; Ambulatory Care Facilities; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Management; Quality of Life	2013
Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Body Weight; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Male; Middle Aged; Models, Biological; Neoplasms; Oxycodone; Tandem Mass Spectrometry	2014
Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study. The American journal of hospice & palliative care, 2014, Volume: 31, Issue:8 Topics: Administration, Oral; Ambulatory Care; Analgesics, Opioid; Chronic Pain; Constipation; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Retrospective Studies; Treatment Outcome	2014
Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients. Clinica chimica acta; international journal of clinical chemistry, 2014, Feb-15, Volume: 429 Topics: Aged; Antiemetics; Female; Genetic Variation; Humans; Male; Middle Aged; Multivariate Analysis; Nausea; Neoplasms; Oxycodone; Prochlorperazine; Prolactin; Receptors, Dopamine D2; Treatment Outcome	2014
Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary? Journal of palliative medicine, 2014, Volume: 17, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Dopamine Antagonists; Drug Interactions; Female; Humans; Inpatients; Japan; Logistic Models; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Oxycodone; Pain; Retrospective Studies; Risk Factors; Sex Distribution; Steroids; Vomiting; Young Adult	2014
African Americans with cancer pain are more likely to receive an analgesic with toxic metabolite despite clinical risks: a mediation analysis study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-01, Volume: 32, Issue:25 Topics: Analgesics; Black or African American; Female; Healthcare Disparities; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Renal Insufficiency, Chronic; Risk Factors	2014
Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain. Journal of pain and symptom management, 2015, Volume: 50, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Analgesics, Opioid; Blood Chemical Analysis; Delayed-Action Preparations; Drug Monitoring; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Mouth; Neoplasms; Oxycodone; Pain	2015
Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:20 Topics: Adult; Aged; Analgesics, Opioid; Economics, Pharmaceutical; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Prognosis	2014
[A study of 31 terminally ill cancer patients who received pure oxycodone injections at home]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Female; Home Care Services; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Terminally Ill	2014
Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain. Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:12 Topics: Analgesics, Opioid; Fentanyl; Humans; Morphine; Neoplasms; Oxycodone; Pain; Serum Albumin	2014
[Switching from oral oxycodone to oxycodone injection - an investigation into the dosage amount ratio]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:1 Topics: Administration, Oral; Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Palliative Care	2015
Prolonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:4 Topics: Aged; Constipation; Defecation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Narcotics; Neoplasms; Oxycodone; Pain; Pain Management; Prospective Studies; Quality of Life	2015
Oxycodone frequently induced nausea and vomiting in oxycodone-naïve patients with hepatic dysfunction. Journal of palliative medicine, 2015, Volume: 18, Issue:5 Topics: Aged; Analgesics, Opioid; Female; Humans; Liver; Male; Nausea; Neoplasms; Oxycodone; Pain; Retrospective Studies; Vomiting	2015
Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2015, Volume: 82, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Female; Humans; Incidence; Japan; Male; Middle Aged; Nausea; Neoplasms; Oxycodone; Pain; Prochlorperazine; Prospective Studies; Risk Factors; Sex Factors; Treatment Outcome; Vomiting	2015
Accuracy of using Diagnosis Procedure Combination administrative claims data for estimating the amount of opioid consumption among cancer patients in Japan. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Codeine; Drug Prescriptions; Female; Fentanyl; Humans; Insurance Claim Review; Japan; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Tramadol	2015
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug design, development and therapy, 2015, Volume: 9 Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neoplasms; Oxycodone; Pain Measurement; Propensity Score; Quality of Life; Retrospective Studies; Rome; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome	2015
Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time. The American journal of hospice & palliative care, 2017, Volume: 34, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Delirium; Drug-Related Side Effects and Adverse Reactions; Female; Fentanyl; Humans; Incidence; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Palliative Care	2017
Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review. Journal of pain & palliative care pharmacotherapy, 2016, Volume: 30, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Quality of Life; Retrospective Studies; Terminal Care; Treatment Outcome	2016
Contribution of Opiate Analgesics to the Development of Infections in Advanced Cancer Patients. The Clinical journal of pain, 2017, Volume: 33, Issue:4 Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Fentanyl; Follow-Up Studies; Humans; Infections; Logistic Models; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain Management; Palliative Care; Retrospective Studies; Risk Factors	2017
Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients. European journal of clinical pharmacology, 2016, Volume: 72, Issue:12 Topics: Aged; Analgesics, Opioid; Cachexia; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Delirium; Depression; Disorders of Excessive Somnolence; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Neoplasms; Oxycodone; Tumor Necrosis Factor-alpha	2016
Dose and Duration of Opioid Use in Patients with Cancer and Noncancer Pain at an Outpatient Hospital Setting in Malaysia. Pain practice : the official journal of World Institute of Pain, 2017, Volume: 17, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Malaysia; Male; Middle Aged; Morphine; Neoplasms; Outpatient Clinics, Hospital; Oxycodone; Pain; Retrospective Studies; Young Adult	2017
Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study. Postgraduate medicine, 2017, Volume: 129, Issue:1 Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Independent Living; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Surveys and Questionnaires; United States	2017
Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes. Oncology, 2008, Volume: 74 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Treatment Outcome	2008
The management of pain due to amputation. Journal of pain & palliative care pharmacotherapy, 2008, Volume: 22, Issue:1 Topics: Adult; Analgesics, Opioid; Anticonvulsants; Delayed-Action Preparations; Disarticulation; Female; Humans; Neoplasms; Oxycodone; Pain; Palliative Care; Phantom Limb	2008
Prescription of opioids in Italy: everything, but the morphine. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:5 Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Drug Prescriptions; Fentanyl; Guideline Adherence; Humans; Italy; Morphine; Neoplasms; Oxycodone; Pain; Practice Guidelines as Topic; Practice Patterns, Physicians'; Time Factors	2009
[Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Injections, Subcutaneous; Male; Medical Audit; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Palliative Care; Time Factors; Young Adult	2009
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Republic of Korea; Time Factors; Young Adult	2010
[Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Drug Prescriptions; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Retrospective Studies; Young Adult	2010
The use of high doses of oxycodone in an acute palliative care unit. The American journal of hospice & palliative care, 2011, Volume: 28, Issue:4 Topics: Acute Disease; Age Factors; Aged; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Palliative Care; Retrospective Studies	2011
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:4 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Spain; Surveys and Questionnaires	2011
Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain. The Clinical journal of pain, 2011, Volume: 27, Issue:8 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Female; Fentanyl; Humans; Logistic Models; Male; Middle Aged; Morphine; Neoplasms; Odds Ratio; Oxycodone; Pain; Pain Management; Predictive Value of Tests; Retrospective Studies; Young Adult	2011
Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Patient Preference; Saliva; Tandem Mass Spectrometry; Time Factors; Young Adult	2012
[Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:6 Topics: Aged; Analgesics, Opioid; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Palliative Care	2011
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study. European journal of clinical pharmacology, 2012, Volume: 68, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Biotransformation; Chronic Pain; Cohort Studies; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Monitoring; Europe; Female; Genetic Association Studies; Humans; Male; Middle Aged; Morphinans; Neoplasms; Oxycodone; Oxymorphone; Polymorphism, Genetic; Severity of Illness Index	2012
Should opioids be used for chronic non-cancer pain? The Medical journal of Australia, 2011, Sep-05, Volume: 195, Issue:5 Topics: Analgesics, Opioid; Australia; Chronic Disease; Drug Utilization; Humans; Inappropriate Prescribing; Neoplasms; Oxycodone; Pain; Utilization Review	2011
Switching from oxycodone to methadone in advanced cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:1 Topics: Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Neoplasms; Oxycodone; Pain; Palliative Care; Prospective Studies; Treatment Outcome	2012
Inconsistencies in opioid equianalgesic ratios: clinical and research implications. Journal of pain & palliative care pharmacotherapy, 2008, Volume: 22, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Opioid; Delayed-Action Preparations; Drug Dosage Calculations; Female; Fentanyl; Humans; Male; Methadone; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic	2008
Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain. Journal of pain and symptom management, 2011, Volume: 42, Issue:6 Topics: Adult; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Fatal Outcome; Female; Fentanyl; Humans; Middle Aged; Neoplasms; Opioid-Related Disorders; Ovarian Neoplasms; Oxycodone; Terminal Care	2011
Should opioids be used for chronic non-cancer pain? The Medical journal of Australia, 2011, Nov-07, Volume: 195, Issue:9 Topics: Analgesics, Opioid; Humans; Inappropriate Prescribing; Neoplasms; Oxycodone; Pain	2011
A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. The Clinical journal of pain, 2012, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Constipation; Female; Gastrointestinal Diseases; Humans; Japan; Laxatives; Magnesium Oxide; Male; Middle Aged; Morphine; Nausea; Neoplasms; Odds Ratio; Oxycodone; Pain; Vomiting	2012
Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients. Journal of pain and symptom management, 2012, Volume: 43, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Cross-Sectional Studies; Europe; Female; Humans; Male; Middle Aged; Narcotics; Neoplasms; Outcome Assessment, Health Care; Oxycodone; Pain; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult	2012
Stop and go strategy for opioid switching requires flexibility. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:6 Topics: Analgesics, Opioid; Drug Substitution; Female; Humans; Male; Methadone; Morphine; Neoplasms; Oxycodone; Pain	2012
Should opioids be used for chronic non-cancer pain? The Medical journal of Australia, 2012, Mar-19, Volume: 196, Issue:5 Topics: Analgesics, Opioid; Humans; Inappropriate Prescribing; Neoplasms; Oxycodone; Pain	2012
Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients. European journal of clinical pharmacology, 2012, Volume: 68, Issue:10 Topics: Acute-Phase Proteins; Aged; Analgesics, Opioid; Asian People; Cachexia; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Serum Albumin; Tablets	2012
Clarifications on oxycodone-naloxone combination in cancer pain management. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:7 Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Combinations; Humans; Naloxone; Narcotic Antagonists; Neoplasms; Oxycodone; Pain	2012
[Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:5 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Retrospective Studies; Tetrahydroisoquinolines; Young Adult	2012
Population pharmacokinetics of oxycodone in patients with cancer-related pain. Journal of pain & palliative care pharmacotherapy, 2012, Volume: 26, Issue:3 Topics: Adult; Aged; Analgesics, Opioid; Biological Availability; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Male; Middle Aged; Models, Biological; Neoplasms; Nonlinear Dynamics; Oxycodone; Pain; Tissue Distribution	2012
Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain. The American journal of hospice & palliative care, 2013, Volume: 30, Issue:7 Topics: Analgesics, Opioid; Humans; Morphine; Neoplasms; Oxycodone; Pain; Retrospective Studies	2013
[Three cases of cancer-related pain for which oxycodone injection was efficacious]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:1 Topics: Aged; Analgesics, Opioid; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain	2013
[Extended release oxycodone. An oral opioid analgesic for cancer patients with chronic pain]. Revue de l'infirmiere, 2002, Issue:85 Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Drug Monitoring; Humans; Neoplasms; Oxycodone; Pain; Patient Education as Topic	2002
Oral oxycodone: new preparation. No better than oral morphine. Prescrire international, 2003, Volume: 12, Issue:65 Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; France; Humans; Morphine; Neoplasms; Oxycodone; Pain; Randomized Controlled Trials as Topic; Treatment Outcome	2003
The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. Pain medicine (Malden, Mass.), 2003, Volume: 4, Issue:2 Topics: Age Factors; Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Narcotics; Neoplasms; Oxycodone; Pain; Retrospective Studies; Sex Factors; Terminal Care	2003
Oxycodone suppositories in the relief of intractable pain. The Practitioner, 1963, Volume: 190 Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Codeine; Humans; Neoplasms; Oxycodone; Pain, Intractable; Suppositories	1963
2003 LeTourneau Award. Freedom from pain. Establishing a constitutional right to pain relief. The Journal of legal medicine, 2003, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Civil Rights; Female; Humans; Male; Meperidine; Narcotics; Neoplasms; Oxycodone; Pain; Patient Rights; Practice Patterns, Physicians'; Substance-Related Disorders	2003
Therapy switching in patients receiving long-acting opioids. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:3 Topics: Administration, Cutaneous; Aged; Analgesics, Opioid; Comorbidity; Delayed-Action Preparations; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain	2004
[Use of opioids against severe cancer pain]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004, Feb-05, Volume: 124, Issue:3 Topics: Analgesics, Opioid; Fentanyl; Humans; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care	2004
Cutting back on high-dosage narcotics. American family physician, 2004, Mar-01, Volume: 69, Issue:5 Topics: Administration, Oral; Adult; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Drug Administration Schedule; Female; Humans; Neoplasms; Opioid-Related Disorders; Oxycodone; Pain; Pain, Postoperative; Patient Participation	2004
[Controlled release oxycodone--a new option in the treatment of severe and very severe pain]. MMW Fortschritte der Medizin, 2004, Aug-05, Volume: 146, Issue:31-32 Topics: Analgesics, Opioid; Arthralgia; Delayed-Action Preparations; Drug Administration Schedule; Humans; Neoplasms; Neuralgia; Oxycodone; Pain; Pain, Postoperative	2004
Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients. Archives of internal medicine, 2004, Nov-22, Volume: 164, Issue:21 Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Drug Combinations; Drug Prescriptions; Female; Humans; Male; Neoplasms; Oxycodone; Pain; Time Factors; Veterans	2004
[Parenteral opioids in end-of-life care in cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:2 Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Fentanyl; Guideline Adherence; Humans; Infusions, Parenteral; Injections, Intravenous; Morphine; Neoplasms; Oxycodone; Pain, Intractable; Palliative Care; Quality of Life; Suppositories	2005
[Pain management for cancer patients with critical pathway on computer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:2 Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Constipation; Critical Pathways; Humans; Microcomputers; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable	2005
Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2005, Volume: 21, Issue:3 Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Neoplasms; Oxycodone; Tetrahydroisoquinolines	2005
No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:1 Topics: Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Analysis of Variance; Decision Making; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Predictive Value of Tests; Prospective Studies; Treatment Outcome	2006
[Pharmacokinetics of controlled-release oxycodone in patients with cancer pain]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:9 Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain	2007
Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:11 Topics: Adult; Aged; Analgesics, Opioid; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Metabolic Clearance Rate; Middle Aged; Models, Theoretical; Neoplasms; Oxycodone; Pain; Tetrahydroisoquinolines	2007
Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1 Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesia; Analgesics, Opioid; Attitude to Death; Codeine; Decision Making; Drug Combinations; Fear; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care; Patient Acceptance of Health Care; Patients; Physician-Patient Relations; Randomized Controlled Trials as Topic; Terminal Care	2008
[Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:13 Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Tetrahydroisoquinolines	2007
[Pain relief therapy: Oxycodone--a new retard opioid with effective analgesic action]. Der Orthopade, 1998, Volume: 27, Issue:7 Suppl Topics: Analgesics, Opioid; Delayed-Action Preparations; Humans; Neoplasms; Oxycodone; Pain	1998
Opioid substitution to reduce adverse effects in cancer pain management. The Medical journal of Australia, 1999, Jan-18, Volume: 170, Issue:2 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Female; Fentanyl; Hospice Care; Humans; Male; Medical Audit; Methadone; Middle Aged; Morphine; Nausea; Neoplasms; Oxycodone; Pain; Pain Measurement; Prospective Studies; Sleep Stages; Sufentanil; Vomiting	1999
Morphine and alternative opioids in cancer pain: the EAPC recommendations. British journal of cancer, 2001, Mar-02, Volume: 84, Issue:5 Topics: Administration, Oral; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Injections, Subcutaneous; Methadone; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care	2001
On the frontlines of old battles. Oncology nursing forum, 2001, Volume: 28, Issue:6 Topics: Analgesics, Opioid; California; Connecticut; Humans; Illicit Drugs; Malpractice; Neoplasms; Oxycodone; Pain; Substance-Related Disorders	2001
Oxycodone and oxycontin. The Medical letter on drugs and therapeutics, 2001, Sep-17, Volume: 43, Issue:1113 Topics: Administration, Oral; Delayed-Action Preparations; Humans; Morphine Dependence; Neoplasms; Opioid-Related Disorders; Oxycodone; Pain; Parenteral Nutrition, Total	2001
Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:5 Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Biological Availability; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Time Factors	1992